Your Next Event in the Series:
Solve the Translational Gap, from Deeper Resolution of Fibrosis Pathology to Clinically Dynamic & Predictive Biomarker Rationale
October 24-26 | Boston
Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit!
Welcome to the 7th Antifibrotic Drug Development (AFDD) Summit
Solve the Translational Gap, from Deeper Resolution of Fibrosis Pathology to Clinically Dynamic & Predictive Biomarker Rationale
As fibrosis stakeholders invest in bolstering their early pipeline to limit early candidate drop off, the 2023 7th Antifibrotic Drug Development (AFDD) Summit explored actionable strategies to take this further.
The AFDD event provided you with skills needed to better interrogate antifibrotic potential and bridge the translational gap:
Pioneering fibrosis quantification with more sensitive fluid and imaging biomarkers that predict, stage and diagnose fibrosis | |
More confident translation to the clinic by harnessing state-of-the-art in-vitro models that truly recapitulate fibrosis | |
Game-changing target ID supercharged by uncovering molecular networks, novel pathways and mapping crosstalk |
With 80+ experts from early-stage research to late translational, this unique scientific forum united industry leaders across fibrotic disease to energize your fibrosis research.
2023 Speaker Faculty Includes:
Previously Attending Companies Include:
Our 2023 Partners:
Expertise Partners:
Innovation Partner:
Exhibition Partner: